Replies to post #705489 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

I could accept three years and bet everyone else here could too. But a public biotech taking in hundreds of millions of investor dollars just to run one single lousy nebulous trial off already existing trials, and while taking twenty years to do so, and while going dark for years at a clip with an agoraphobic CEO CFO only to occasionally PR new employees who disappears soon after, that's not development. At least not of the many I've ever been in.


>>Pre revenue companies lose money. Many small businesses lose money for the first 3 years while spending on customer acquisition and overhead. Biotechs very typically spend over $1,000,000,000 getting just a single indication drug to market and immunotherapies have taken 10-20+ years on average to develop to the point of marketing.

[learningcurve2020]

By starting??? They've gone nowhere! It's the disciples here who carry on about "Platform tech" not management. Direct sits shelved forever. L goes nowhere with other cancers. They can't even get a solid number on GBM and you pretend they're going to treat 85% of all diseases. Crazy. That statement alone should get you kicked out of here!


>>NWBO has spent somewhat more than this while developing an entire platform technology by starting with a single indication Phase 3 trial that has the potential as a platform to treat about 85% of all diseases.



No they have not. To date nobody is paying for anything except shareholders. Add to the problems LP inserted her private CDMO into operations.


>>Not only this but they developed de novo commercial scale manufacturing along with it.

[learningcurve2020]

I would not wear that as a badge of honor. Wrong! I've been bringing up the GC red flag forever here but you just chose to ignore it, and now you're paying for it, assuming you're even a real shareholder.

>>Looking at that ongoing concern mention you should note that it has been on the books each and every year I have been invested and that includes from prices of $.14 to $12.54. Funny that this ongoing concern statement somehow becomes so much more important to you now when they are closer to approval and worldwide commercial manufacturing scalability than ever before; ).


It's a fake double bottom and you know it. Dismissing all the years past and the reverse splits is your choice but a dumb one.


>>So 2020 was “magical” because the lifetime double bottom was called on this board

What? Statement like this make me certain you're a phony.

>>and since you are so concerned with investors here making money then that would have been the time to back up the truck so to speak.


When did I do that? More phoniness.

>>Since you identify yourself as a trader


I don't make buy or sell calls.

>>and seem to want to compare your calls to mine where was your call back then?; ).


Yes, It's called averaging down forever.

>>My strategy is not a trading strategy with accumulation, just accumulation itself
until the target is hit or the stock gets passed on with a target for others in mind. My success with this strategy will not be determined fully until a later date.

Liar.

>>For now, I’m still in the black with all my accounts


Only shows I'm communicating with a delusional cult member.

>>As regards Mr. Buffet, he has seen what happens to those who mess with Linda. He’ll wait for the manufacturing with Flaskworks to pass muster and a different exchange to trade on just like other institutions will. He can then chose to either invest in NWBO directly or in others who will connect themselves to them that he likely is already invested in. Feel free to bookmark this post and check back in about 2 years when Flaskworks is fully ramping ; ). Best wishes.